A therapeutic agent for the treatment of diabetic neuropathy which comprises (.+-.)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]-ethyl]- dimethylsulfonium p-toluenesulfonate of the formula (1) as an active ingredient. ##STR00001##